Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Gross Margin (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of Gross Margin data on record, last reported at 593.43% in Q3 2025.

  • For Q3 2025, Gross Margin fell 65419.0% year-over-year to 593.43%; the TTM value through Sep 2025 reached 82.36%, up 2000.0%, while the annual FY2024 figure was 59.76%, 4306.0% up from the prior year.
  • Gross Margin reached 593.43% in Q3 2025 per COLL's latest filing, down from 57.65% in the prior quarter.
  • Across five years, Gross Margin topped out at 63.38% in Q1 2021 and bottomed at 593.43% in Q3 2025.
  • Average Gross Margin over 5 years is 18.52%, with a median of 57.65% recorded in 2025.
  • Peak YoY movement for Gross Margin: surged 4328bps in 2022, then tumbled -65419bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 4.87% in 2021, then surged by 888bps to 38.41% in 2022, then skyrocketed by 65bps to 63.19% in 2023, then decreased by -15bps to 54.02% in 2024, then plummeted by -1199bps to 593.43% in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 593.43% in Q3 2025, 57.65% in Q2 2025, and 54.75% in Q1 2025.